Results

Total Results: over 10,000 records

Showing results for "stages".

  1. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
    April 01, 2019 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
    June 20, 2019 - rate of breast cancer is an estimated 89.7%, ranging from 98.7% when cancer is diagnosed at localized stages
  3. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - Some tools that might meet these criteria include: • Ages and Stages Questionnaire (ASQ), 2 months … • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy … These measures are applicable to changes across the developmental stages of infancy and early childhood … We have identified a group of acceptable screens (Ages and Stages Questionnaire (ASQ), 2 months – 5
  4. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - Some tools that might meet these criteria include: • Ages and Stages Questionnaire (ASQ), 2 months … • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy … These measures are applicable to changes across the developmental stages of infancy and early childhood … We have identified a group of acceptable screens (Ages and Stages Questionnaire (ASQ), 2 months – 5
  5. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - Some tools that might meet these criteria include: • Ages and Stages Questionnaire (ASQ), 2 months … • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy … These measures are applicable to changes across the developmental stages of infancy and early childhood … We have identified a group of acceptable screens (Ages and Stages Questionnaire (ASQ), 2 months – 5
  6. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - Some tools that might meet these criteria include: • Ages and Stages Questionnaire (ASQ), 2 months … • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy … These measures are applicable to changes across the developmental stages of infancy and early childhood … We have identified a group of acceptable screens (Ages and Stages Questionnaire (ASQ), 2 months – 5
  7. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - Some tools that might meet these criteria include: • Ages and Stages Questionnaire (ASQ), 2 months … • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy … These measures are applicable to changes across the developmental stages of infancy and early childhood … We have identified a group of acceptable screens (Ages and Stages Questionnaire (ASQ), 2 months – 5
  8. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - Some tools that might meet these criteria include: • Ages and Stages Questionnaire (ASQ), 2 months … • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy … These measures are applicable to changes across the developmental stages of infancy and early childhood … We have identified a group of acceptable screens (Ages and Stages Questionnaire (ASQ), 2 months – 5
  9. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - Some tools that might meet these criteria include: • Ages and Stages Questionnaire (ASQ), 2 months … • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy … These measures are applicable to changes across the developmental stages of infancy and early childhood … We have identified a group of acceptable screens (Ages and Stages Questionnaire (ASQ), 2 months – 5
  10. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - Some tools that might meet these criteria include: • Ages and Stages Questionnaire (ASQ), 2 months … • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy … These measures are applicable to changes across the developmental stages of infancy and early childhood … We have identified a group of acceptable screens (Ages and Stages Questionnaire (ASQ), 2 months – 5
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
    July 26, 2012 - Disposition of Comments Report for Recurrent Nephrolithiasis in Adults http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1035 Published Online: July 26, 2012 Comparative Effectiveness Research Review Disposition of Comments Report Research Revie…
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
    July 26, 2012 - Disposition of Comments Report for Recurrent Nephrolithiasis in Adults http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1035 Published Online: July 26, 2012 Comparative Effectiveness Research Review Disposition of Comments Report Research Revie…
  13. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy
  14. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy
  15. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy
  16. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy
  17. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy
  18. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy
  19. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy
  20. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - • The extent to which the measure is applicable to changes across developmental stages (e.g., infancy